Role of endothelin a receptor in colon cancer metastasis: In vitro and in vivo evidence

Molecular Carcinogenesis

Volumn 53, Issue S1, 2014, Pages

  Nie, Shaolin ^a,b   Zhou, Jumei ^b   Bai, Fei ^b   Jiang, Bonian ^b   Chen, Juying ^b   Zhou, Jianping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cell survival; Colon cancer; Endothelin A receptor; Endothelin 1; Metastasis; Phosphatidylinositol 3 kinase (PI3K)

Indexed keywords

CELL SURVIVAL; COLON CANCER; ENDOTHELIN A RECEPTOR; ENDOTHELIN-1; METASTASIS; PHOSPHATIDYLINOSITOL 3-KINASE (PI3K);

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; COLONIC NEOPLASMS; ENDOTHELIN-1; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTOR, ENDOTHELIN A; TUMOR CELLS, CULTURED;

EID: 84894458350     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22036     Document Type: Article

References (31)

1. Jemal A, Siegel R, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J Clin 2009; 59:225-249.
2. Zhang S, Cui Y, Weng Z, Gong X, Chen M, Zhong B. Changes on the disease pattern of primary colorectal cancers in Southern China: A retrospective study of 20 years. Int J Colorectal Dis 2009; 24:943-949.
3. Jiang SX, Wang XS, Geng CH, Wang GY. Altering trend of clinical characteristics of colorectal cancer: A report of 3, 607 cases. Ai Zheng 2009; 28:54-56.
4. Grant K, Knowles J, Dawas K, Burnstock G, Taylor I, Loizidou M. Mechanisms of endothelin 1-stimulated proliferation in colorectal cancer cell lines. Br J Surg 2007; 94:106-112.
5. Lorenz M, Staib-Sebler E, Hochmuth K, et al. Surgical resection of liver metastases of colorectal carcinoma: Short and long-term results. Semin Oncol 2000; 27:112-119.
6. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
7. Shankar A, Loizidou M, Aliev G, et al. Raised endothelin 1 levels in patients with colorectal liver metastases. Br J Surg 1998; 85:502-506.
8. Ali H, Dashwood M, Dawas K, Loizidou M, Savage F, Taylor I. Endothelin receptor expression in colorectal cancer. J Cardiovasc Pharmacol 2000; 36:S69-S71.
9. Bagnato A, Salani D, Di Castro V, et al. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: Evidence for an autocrine role in tumor growth. Cancer Res 1999; 59:720-727.
10. Douglas ML, Richardson MM, Nicol DL. Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma. Cancer 2004; 100:2118-2124.
11. Shankar A, Loizidou M, Aliev G, et al. Raised ET-1 levels in patients with colorectal liver metastases. Br J Surg 1998; 85:502-506.
12. Ali H, Dashwood M, Dawas K, Loizidou M, Savage F, Taylor I. Endothelin receptor expression in colorectal cancer. J Cardiovasc Pharm 2000; 36:S69-S71.
13. Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: Emerging role in cancer. Nat Rev Cancer 2003; 3:110-116.
14. Yu L, Wang CY, Miao L, Du X, Mayer D, Zhang J. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinol 2011; 152:773-781.
15. Thalheimer A, Otto C, Bueter M, et al. The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer. BMC Cancer 2009; 9:29.
16. Rosanò L, Cianfrocca R, Spinella F, et al. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res 2011; 17:2350-2360.
17. Liakou P, Tepetes K, Germenis A, et al. Expression patterns of endothelin-1 and its receptors in colorectal cancer. J Surg Oncol 2012; 105:643-649.
18. Asham E, Shankar A, Loizidou M, et al. Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br J Cancer 2001; 85:1759-1763.
19. Hopkin K, Edwards P, Harris A. et al., Cancer. In: Alberts B, Johnson A, Lewis J, editors. Molecular biology of the cell. 4th ed. New York: Garland Science; 2002. pp. 1324-1325.
20. Zhao Y, Liao Q, Zhu Y, Long H. Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis. Clin Orthop Relat Res 2011; 469:3190-3199.
21. Felx M, Guyot MC, Isler M, et al. Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin Sci (Lond) 2006; 110:645-654.
22. Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic. Invest New Drugs 1999; 4:343-359.
23. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad O. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 2004; 10:1593-1598.
24. Li ZY, Ni S, Yang X, Kiviat N, Lieber A. Xenograft models for liver metastasis: Relationship between tumor morphology and adenovirus vector transduction. Mol Ther 2004; 5:650-657.
25. Kollmar O, Schilling MK, Menger MD. Experimental liver metastasis: Standards for Local cell implantation to study isolated tumor growth in mice. Clin Exp Metastasis 2004; 5:453-460.
26. Bouvet M, Tsuji K, Yang M, Jiang P, Moossa AR, Hoffman RM. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 2006; 23:11293-11297.
27. Bagnato A, Loizidou M, Pflug BR, Curwen J, Growcott J. Role of the endothelin axis its antagonists in the treatment of cancer. Br J Pharmacol 2011; 163:220-233.
28. Grimshaw MJ, Hagemann T, Ayhan A, Gillett CE, Binder C, Balkwill FR. A role for endothelin-2 its receptors in breast tumor cell invasion. Cancer Res 2004; 64:2461-2468.
29. Tanese K, Fukuma M, Ishiko A, Sakamoto M. Endothelin-2 is upregulated in basal cell carcinoma under control of Hedgehog signaling pathway. Biochem Biophys Res Commun 2010; 391:486-491.
30. Wiesmann F, Veeck J, Galm O, et al. Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer. Breast Cancer Res 2009; 11:R34.
31. Lambert LA, Whyteside AR, Turner AJ, Usmani BA. Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion. Br J Cancer 2008; 99:1114-1120.